Fennec Pharmaceuticals Inc (FRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,307 | 1,663 | 2,303 | 5,297 | 5,947 |
| Other current assets | 17 | 8 | 6 | 19 | 8 |
| TOTAL | $2,372 | $1,752 | $2,365 | $5,351 | $5,993 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $2,372 | $1,752 | $2,365 | $5,351 | $5,993 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 308 | 212 | 259 | 342 | 272 |
| Accrued Expenses | 132 | 132 | 423 | 52 | 195 |
| Other current liabilities | 1,319 | 2,863 | 6,640 | 5,077 | 10,450 |
| TOTAL | $1,759 | $3,207 | $7,322 | $5,471 | $10,917 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,759 | $3,207 | $7,322 | $5,471 | $10,917 |
| Shareholders' Equity | |||||
| Common Shares | 68,656 | 66,790 | 65,952 | 0 | 0 |
| Retained earnings | -110,874 | -108,698 | -110,543 | -105,380 | -108,813 |
| Other shareholders' equity | 1,243 | 1,243 | 1,243 | 1,243 | 1,243 |
| TOTAL | $613 | $-1,455 | $-4,957 | $-120 | $-4,924 |
| Total Liabilities And Equity | $2,372 | $1,752 | $2,365 | $5,351 | $5,993 |